This is further supported by the increase in the circulating levels of CCL20 observed in this cohort of patients, in our previous study [22], and by a number of studies that have detected infiltration of Treg cells in the tumor microenvironment of HCC and CCA patients [23,24,25,26]. This evidence concerns the gene CCL20 and cholangiocarcinoma.